Search results

Articles (6)

Journals (0)

1-6 of 6 results for FDA two-study paradigm

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted access

Other

First published 1999-1

One Large,Well-Designed,Multicenter Study as an Alternative to the Usual FDA Paradigm

Lloyd D. Fisher

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2004-3

A Brief History of Immunotoxicology and a Review of the Pharmaceutical Guidelines

Jack H. Dean

International Journal of Toxicology

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2018-8

The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases

Manuel X Duval

Experimental Biology and Medicine

Retricted access

Research article

First published 2015-11

Reconceptualizing Consent for Direct-to-Consumer Health Services

Kayte Spector-Bagdady

American Journal of Law & Medicine

Retricted access

Research article

First published 2001-8

Engineered antibodies take center stage

James S. Huston, Andrew J.T. George

Human Antibodies